Alzheimer’s Disease/Dementia News

People who adhered more closely to the Mediterranean diet had a lower risk for dementia, regardless of genetic risk, according to data published in BMC Medicine.

A new blood test may be able to detect Alzheimer’s disease-related pathology up to 10 years before symptoms appear, according to a press release from Durin Technologies.

Biopharmaceutical company Aptinyx reported its drug for cognitive impairment was not efficacious in a phase 2 clinical trial investigating its use in patients with Parkinson’s disease and Lewy body dementia, according to a press release.

A noninvasive focused ultrasound technology was used in an FDA-approved clinical trial to treat Alzheimer’s disease, according to a press release.

Linus Health announced a collaboration with Goizueta Institute @Emory Brain Health and The Seavey Clinic at Emory Healthcare to implement digital cognitive assessments in primary care for early detection of Alzheimer’s disease.

CN Diagnostics announced it has received a $15 million program-related investment from GHR Foundation to support and advance the PrecivityAD2 blood test for the detection of Alzheimer’s disease.

Differences in dementia risk between men and women may be attributable to their country’s economy and individual characteristics, according to findings of an international meta-analysis published in Alzheimer’s & Dementia.

Education quality was associated with dementia risk later in life, according to findings published in JAMA Neurology.

Maintaining a mild to moderate level of alcohol consumption was associated with a decreased risk of dementia, according to a study published in JAMA Network Open.

White individuals who frequently used sleep medication had a greater risk for dementia compared with those who rarely or never used them, though the same association was not found in Black individuals, a new study found.